Holm-Jorgensen Rasmus
Insider CIK 1950496 · ACRV Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-03-01 | 2025-03-04 | 109,309 | — | $0 | 109,309 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-02-14 | 2025-02-19 | 434 | $5.42 | $2.4K | 26,088 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-11-14 | 2024-11-18 | 368 | $7.92 | $2.9K | 26,522 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-08-14 | 2024-08-16 | 368 | $7.02 | $2.6K | 26,890 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-05-14 | 2024-05-16 | 368 | $8.36 | $3.1K | 27,258 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-11-27 | 90,090 | — | $0 | 90,090 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-02-14 | 2024-02-16 | 434 | $3.40 | $1.5K | 27,626 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2023-11-14 | 2023-11-16 | 1,470 | $5.08 | $7.5K | 28,060 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | M Exercise deriv | 2023-06-16 | 2023-06-20 | 9,500 | — | $0 | 183,119 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | M Exercise | 2023-06-16 | 2023-06-20 | 9,500 | $3.63 | $34.5K | 29,530 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2022-11-14 | 2022-11-16 | 60,090 | — | $0 | 60,090 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2022-11-14 | 2022-11-16 | 20,030 | — | $0 | 20,030 | SEC↗ |